Cargando…
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity
We have recently described a novel modular targeting platform for T cell recruitment that not only efficiently replaces but also is superior to conventional T cell-engaging bispecific antibodies as it allows for the flexible targeting of several antigens and the delivery of co-stimulatory ligands to...
Autores principales: | Cartellieri, Marc, Arndt, Claudia, Feldmann, Anja, von Bonin, Malte, Ewen, Eva-Maria, Koristka, Stefanie, Michalk, Irene, Stamova, Slava, Berndt, Nicole, Gocht, Anne, Bornhäuser, Martin, Ehninger, Gerhard, Schmitz, Marc, Bachmann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909541/ https://www.ncbi.nlm.nih.gov/pubmed/24498554 http://dx.doi.org/10.4161/onci.26770 |
Ejemplares similares
-
Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8
por: Michalk, Irene, et al.
Publicado: (2014) -
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
por: Aliperta, R, et al.
Publicado: (2015) -
A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells
por: Cartellieri, Marc, et al.
Publicado: (2014) -
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
por: Bachmann, Dominik, et al.
Publicado: (2017) -
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
por: Cartellieri, M, et al.
Publicado: (2016)